MX2010005087A - Formulacion solida de liberacion rapida, preparacion y uso de la misma. - Google Patents

Formulacion solida de liberacion rapida, preparacion y uso de la misma.

Info

Publication number
MX2010005087A
MX2010005087A MX2010005087A MX2010005087A MX2010005087A MX 2010005087 A MX2010005087 A MX 2010005087A MX 2010005087 A MX2010005087 A MX 2010005087A MX 2010005087 A MX2010005087 A MX 2010005087A MX 2010005087 A MX2010005087 A MX 2010005087A
Authority
MX
Mexico
Prior art keywords
preparation
solid formulation
fast release
release solid
florfenicol
Prior art date
Application number
MX2010005087A
Other languages
English (en)
Inventor
Robert D Simmons
Keith Alan Freehauf
Serena Tongiani
Original Assignee
Intervet Int Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intervet Int Bv filed Critical Intervet Int Bv
Publication of MX2010005087A publication Critical patent/MX2010005087A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin

Abstract

La presente invención describe una formulación estable químicamente de florfenicol, (y compuestos estructuralmente relacionados) en composiciones tal como polvos mezclados solubles, gránulos, tabletas de disolución rápida o pellas adecuadas para liberación rápida del fármaco en agua, y para métodos y kits para el tratamiento de animales con composiciones acuosas que incluyen florfenicol.
MX2010005087A 2007-11-09 2008-11-05 Formulacion solida de liberacion rapida, preparacion y uso de la misma. MX2010005087A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US98690207P 2007-11-09 2007-11-09
PCT/US2008/082427 WO2009061780A1 (en) 2007-11-09 2008-11-05 Fast release solid formulation, preparation and use thereof

Publications (1)

Publication Number Publication Date
MX2010005087A true MX2010005087A (es) 2010-05-21

Family

ID=40266012

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2010005087A MX2010005087A (es) 2007-11-09 2008-11-05 Formulacion solida de liberacion rapida, preparacion y uso de la misma.

Country Status (16)

Country Link
US (1) US7968599B2 (es)
EP (1) EP2217207B1 (es)
JP (1) JP5193308B2 (es)
KR (1) KR20100085162A (es)
CN (1) CN101909600A (es)
AU (1) AU2008324852A1 (es)
BR (1) BRPI0818906A2 (es)
CA (1) CA2705063C (es)
CO (1) CO6270302A2 (es)
ES (1) ES2715049T3 (es)
MX (1) MX2010005087A (es)
NZ (1) NZ585219A (es)
PL (1) PL2217207T3 (es)
RU (1) RU2010123282A (es)
WO (1) WO2009061780A1 (es)
ZA (1) ZA201003262B (es)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY146351A (en) 2003-05-29 2012-08-15 Schering Plough Ltd Compositions for treating infection in cattle and swine
CA2672795A1 (en) * 2006-12-13 2008-06-26 Schering-Plough Ltd. Water-soluble prodrugs of chloramphenicol, thiamphenicol, and analogs thereof
CA2732017A1 (en) * 2008-07-30 2010-02-04 Intervet International B.V. Process for preparing oxazoline-protected aminodiol compounds useful as intermediates to florfenicol
BRPI1002023A2 (pt) 2010-03-01 2011-10-25 Nanocore Biotecnologia S A forma farmacêutica sólida de dissolução rápida para tratamento de infecções bacterianas
CN101966200A (zh) * 2010-07-26 2011-02-09 天津生机集团股份有限公司 用于治疗禽消化道细菌感染的组合物及其制备方法
CN102727447A (zh) * 2011-04-11 2012-10-17 商丘市康森动物药品研究所 一种氟苯尼考控释制剂及其制备方法
CN102526007B (zh) * 2012-01-11 2013-07-17 山东鲁抗舍里乐药业有限公司 一种氟苯尼考掩味制剂及其制备方法
CN102657614A (zh) * 2012-05-03 2012-09-12 青岛绿曼生物工程有限公司 一种氟苯尼考固体分散体的制备方法
CN102697730A (zh) * 2012-05-07 2012-10-03 郑州后羿制药有限公司 一种氟苯尼考可溶性粉及其制备方法
CN102885777B (zh) * 2012-10-25 2014-07-16 上海邦森生物科技有限公司 氟苯尼考粉剂组合物及其制备方法
CN103127019B (zh) * 2013-03-22 2015-04-22 成都乾坤动物药业有限公司 一种氟苯尼考分散片及其制备方法和用途
CN104162144B (zh) * 2013-08-30 2016-04-20 郑州后羿制药有限公司 一种复方氟苯尼考混悬液及其制备方法
WO2016193880A1 (en) * 2015-05-29 2016-12-08 Jubilant Generics Limited Immediate release pharmaceutical composition of tizanidine
CN105168144A (zh) * 2015-10-29 2015-12-23 林州中农生物肽科技有限公司 一种氟苯尼考可溶性粉及其制备方法
CN106902097B (zh) * 2015-12-21 2020-01-07 瑞普（天津）生物药业有限公司 一种可改善药物生物利用度的药物组合物
CN109498580B (zh) * 2018-12-13 2019-09-06 广东温氏大华农生物科技有限公司 一种氟苯尼考颗粒制剂及其制备工艺
CN110478314B (zh) * 2019-09-27 2022-01-11 上海明磊邦森生物科技(登封)有限公司 能以任意比例与水互溶的氟苯尼考溶液及其制备方法和应用
JP7463869B2 (ja) 2020-06-11 2024-04-09 株式会社アイシン 回転電機
CN113171345B (zh) * 2021-05-26 2022-09-30 浙江耐司康药业有限公司 氟苯尼考可溶性粉及其制备方法
CN113318077B (zh) * 2021-06-07 2022-11-15 山东国邦药业有限公司 一种水产专用的粘附型氟苯尼考粉及其制备方法
CN113425680A (zh) * 2021-06-23 2021-09-24 山东国邦药业有限公司 一种长效稳定的氟苯尼考干混悬剂及其制备方法
CN116036020A (zh) * 2022-08-31 2023-05-02 瑞普（天津）生物药业有限公司 一种高生物利用度的氟苯尼考粉剂及其制备方法
CN116019771A (zh) * 2022-09-09 2023-04-28 沈阳伟嘉生物技术有限公司 一种氟苯尼考可混饮无定形固体分散体制剂及其制备方法和用途

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES488154A0 (es) * 1979-02-05 1981-04-16 Schering Corp Un procedimiento para la preparacion de un compuesto d-(treo-1-aril-2-acilamido-3-fluor-1-propanol
US5105009A (en) * 1983-06-02 1992-04-14 Zambon S.P.A. Intermediates for the preparation of 1-(phenyl)-1-hydroxy-2-amino-3-fluoropropane derivatives
IT1173213B (it) * 1984-02-03 1987-06-18 Zambon Spa Procedimento per fluorurare alcuni derivati dall'1l-fenil-2-ammino-1,3-propandiolo e loro intermedi
US5332835A (en) * 1984-02-03 1994-07-26 Zambon S.P.A. Process for fluorinating 1-phenyl-2-amino-1,3-propanediol compounds and new oxazoline compounds useful in this process
US4582918A (en) * 1984-09-19 1986-04-15 Schering Corporation Preparation of intermediates for (threo)-1-aryl-2-acylamido-3-fluoro-1-propanols
US4973750A (en) * 1984-09-19 1990-11-27 Schering Corporation Preparation of (threo)-1-aryl-2-acylamido-3-fluoro-1-propanols
US5227494A (en) * 1988-09-14 1993-07-13 Schering Corporation Process for preparing oxazoline compounds
US4876352A (en) * 1988-09-14 1989-10-24 Schering Corporation Pressurized fluorination of hydroxy alkyl groups
HU9301182D0 (en) * 1990-10-25 1993-08-30 Schering Corp Method for producing fluoro-phenicole, its analogues and intermediary compounds
DE9216543U1 (es) * 1992-12-04 1993-03-25 Cerpraecis Anwendungen Fuer Ingenieurkeramik Gmbh, 4650 Gelsenkirchen, De
US5352832A (en) 1992-12-18 1994-10-04 Schering Corporation Asymmetric process for preparing florfenicol, thiamphenicol chloramphenicol and oxazoline intermediates
US5663361A (en) * 1996-08-19 1997-09-02 Schering Corporation Process for preparing intermediates to florfenicol
US6168805B1 (en) * 1998-05-07 2001-01-02 Endo Pharmaceuticals, Inc. Aqueous process for manufacturing paroxetine solid dispersions
RU2216319C1 (ru) * 1999-11-30 2003-11-20 Панацея Биотек Лимитед Быстрорастворимая фармацевтическая композиция в виде твердой лекарственной формы с пролонгированным сладким вкусом и способ ее получения
US6919378B2 (en) * 2000-10-11 2005-07-19 Cephalon, Inc. Pharmaceutical solutions of modafinil compounds
CN1947699A (zh) * 2006-11-04 2007-04-18 庄晓峰 一种水溶性氟苯尼考的生产方法
WO2008085310A2 (en) * 2006-12-19 2008-07-17 Schering-Plough Ltd. Effervescent formulations of florfenicol for addition in drinking water systems

Also Published As

Publication number Publication date
EP2217207A1 (en) 2010-08-18
AU2008324852A1 (en) 2009-05-14
JP2011503083A (ja) 2011-01-27
CA2705063A1 (en) 2009-05-14
BRPI0818906A2 (pt) 2015-05-12
CO6270302A2 (es) 2011-04-20
ZA201003262B (en) 2011-04-28
WO2009061780A1 (en) 2009-05-14
RU2010123282A (ru) 2011-12-20
PL2217207T3 (pl) 2019-05-31
CA2705063C (en) 2013-02-05
US7968599B2 (en) 2011-06-28
JP5193308B2 (ja) 2013-05-08
ES2715049T3 (es) 2019-05-31
EP2217207B1 (en) 2019-01-09
KR20100085162A (ko) 2010-07-28
NZ585219A (en) 2012-11-30
CN101909600A (zh) 2010-12-08
US20090156683A1 (en) 2009-06-18

Similar Documents

Publication Publication Date Title
MX2010005087A (es) Formulacion solida de liberacion rapida, preparacion y uso de la misma.
HK1128471A1 (en) Heterocyclic non-nucleoside compounds, their preparation, pharmaceutical composition and their use as antiviral agents
DK2321321T3 (da) Triazolo [4,5-d]pyramidinderivater og anvendelse deraf som purinreceptorantagonister
BRPI0915084B8 (pt) composto, e, composição farmacêutica
PE20061449A1 (es) Composiciones farmaceuticas comprendiendo imatinib y un retardador de liberacion
UY30364A1 (es) Arilimidazolonas y ariltriazolonas sustituidas asi como su uso
AR077199A1 (es) Composicion farmaceutica y procedimiento de tratamiento para la anticoncepcion de emergencia
WO2008101682A3 (en) Iminipyridine derivatives and their uses as microbiocides
CL2007002316A1 (es) Compuestos derivados de pirimidina, inhibidores de pi3k; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto en enfermedades proliferativas como cancer.
NO20090554L (no) Farmasoytiske preparater av memantin
CL2007001648A1 (es) Compuesto derivado de leptomicina; conjugado que comprende agente de unión a células unido a uno o mas de dichos derivados; composiciones farmacéuticas que comprenden dicho derivado o conjugado; util en el tratamiento del cancer; proceso de preparacion de un compuesto o de un conjugado de un derivado de leptomicina.
ZA200809864B (en) Pharmaceutical formulations for the sustained release of active ingredients(s), as well as their applications, especially therapeutic
UA98804C2 (ru) Катехоламиновые производные и фармацевтическая композиция на их основе
WO2008012470A3 (fr) Derives d'imidazolones substitues, preparation et utilisations
UA103025C2 (ru) Твердая композиция лекарственного средства замедленного высвобождения
WO2008084504A3 (en) Pharmaceutical compositions of angiotensin ii receptor blockers
MY149854A (en) Novel aminoalcohol-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicaments
IL191758A0 (en) Composition with sustained release of the active ingredient, process for the preparation thereof and use thereof
MX347105B (es) Composiciones farmaceuticas que comprenden hidromorfona y naloxona.
MX2009008084A (es) Derivados de 5,6,7,8-tetrahidropteridina como inhibidores de hsp90.
CL2007002919A1 (es) Compuestos derivados de pirido[2,3-b]indol, inhibidores de quinasa; procedimiento de preparacion; composicion farmaceutica; y su uso para tratar cancer, entre otras enfermedades.
CL2009001267A1 (es) Compuestos derivados de triciclos nitrogenados, con actividad antibacteriana; procedimiento de preparacion; composicion farmceutica que los comprende; para el tratamiento de la tuberculosis.
MA33022B1 (fr) Composition à libération contrôlée pour produire une préparation à libération prolongée contenant de l'udénafil
GEP20125392B (en) Tricyclic compounds and pharmaceutical use thereof
ZA200905126B (en) Use of compounds of formula (i) and/or (II) for the preservation of human or animal bodies, and compositions containing the same

Legal Events

Date Code Title Description
FG Grant or registration